GR
Galera Therapeutics, Inc.
GRTX · OTC
$17.15 +9.80% (+$1.53)
Market Cap $3.56B
P/E Ratio 23.91x
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
30 /100
Expensive P/B 709.35x
P/E 23.91x
P/S N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
21 /100
Poor ROA 2,417.83%
Asset turnover 0.00x
ROIC 114.16%
Debt
100 /100
Low Current ratio 5.31x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
4 /100
Unstable EPS volatility 273.83%
Profitable years 1
Beta 2.61x
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre GRTX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
J. Mel Sorensen
Employees
3
Headquarters
Malvern